Mark J Levin's Net Worth

$140 Million

Who is Mark J Levin?

Mark J Levin has an estimated net worth of $140 Million. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., CONSTELLATION PHARMACEUTICALS INC, Fulcrum Therapeutics, Inc., Revolution Medicines, Inc., PLIANT THERAPEUTICS, INC., Editas Medicine, Inc., Jounce Therapeutics, Inc., Voyager Therapeutics, Inc., Blueprint Medicines Corp, Nurix Therapeutics, Inc., Global Blood Therapeutics, Inc., Sage Therapeutics, Inc., Relay Therapeutics, Inc., MyoKardia Inc, Neon Therapeutics, Inc., Foundation Medicine, Inc., ZAFGEN, INC., Allena Pharmaceuticals, Inc., Decibel Therapeutics, Inc., Eleven Biotherapeutics, Inc., CytomX Therapeutics, Inc., and MILLENNIUM PHARMACEUTICALS INC.

SEC CIK

Mark J Levin's CIK is 0001180428

Past Insider Trading and Trends

2005 was Mark J Levin's most active year for acquiring shares with 9 total transactions. Mark J Levin's most active month to acquire stocks was the month of May. 2007 was Mark J Levin's most active year for disposing of shares, totalling 851 transactions. Mark J Levin's most active month to dispose stocks was the month of October. 2005 saw Mark J Levin paying a total of $6,232,514.93 for 1,535,844 shares, this is the most they've acquired in one year. In 2008 Mark J Levin cashed out on 4,382,974 shares for a total of $56,918,624.00, their largest year based on trade value.